Cardiovascular risk and acute coronary syndrome in giant cell arteritis: A population-based retrospective cohort study

Prabhu D. Udayakumar, Arun K. Chandran, Cynthia Crowson, Kenneth J Warrington, Eric Lawrence Matteson

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Objective. To assess the occurrence of acute coronary syndrome (ACS) in patients with giant cell arteritis (GCA) compared to subjects without GCA. Methods. We retrospectively reviewed a population-based incidence cohort of Olmsted County, Minnesota residents with GCA diagnosed in 1950-2009. We compared this cohort with a cohort of patients without GCA of similar age, sex, and calendar year from the same population. Results. The study included 245 patients with GCA and 245 non-GCA subjects. The mean ± SD Framingham cardiovascular risk score was 30% ± 19% in GCA patients and 34% ± 23% in non-GCA subjects (P = 0.096) at the incidence/index date. Diabetes mellitus was significantly less common in GCA patients than non-GCA subjects at the index date. The mean high-density lipoprotein was higher and triglycerides were lower, with fewer patients taking lipid-lowering medications in the GCA cohort compared to the non-GCA cohort at the index date. During followup, no difference between the 2 cohorts was noted in the overall rate of ACS events (hazard ratio 0.74, 95% confidence interval 0.44-1.26). Overall thrombosis in myocardial infarction scores were similar in both cohorts. Revascularization procedures were done less frequently in GCA than in non-GCA subjects (19% versus 50%; P = 0.015). Post-ACS hospital length of stays and complications were similar in both cohorts. Conclusion. Multiple cardiovascular risk factors are less atherogenic at incidence of GCA. There is no overall increased risk of ACS in patients with GCA.

Original languageEnglish (US)
Pages (from-to)396-402
Number of pages7
JournalArthritis Care and Research
Volume67
Issue number3
DOIs
StatePublished - Mar 1 2015

Fingerprint

Giant Cell Arteritis
Acute Coronary Syndrome
Cohort Studies
Retrospective Studies
Arteritis
Population
Length of Stay
Incidence
HDL Lipoproteins
Diabetes Mellitus
Triglycerides
Thrombosis
Myocardial Infarction
Confidence Intervals

ASJC Scopus subject areas

  • Rheumatology

Cite this

Cardiovascular risk and acute coronary syndrome in giant cell arteritis : A population-based retrospective cohort study. / Udayakumar, Prabhu D.; Chandran, Arun K.; Crowson, Cynthia; Warrington, Kenneth J; Matteson, Eric Lawrence.

In: Arthritis Care and Research, Vol. 67, No. 3, 01.03.2015, p. 396-402.

Research output: Contribution to journalArticle

@article{e0bdc565758f46af8ed7d98aabe3b7b7,
title = "Cardiovascular risk and acute coronary syndrome in giant cell arteritis: A population-based retrospective cohort study",
abstract = "Objective. To assess the occurrence of acute coronary syndrome (ACS) in patients with giant cell arteritis (GCA) compared to subjects without GCA. Methods. We retrospectively reviewed a population-based incidence cohort of Olmsted County, Minnesota residents with GCA diagnosed in 1950-2009. We compared this cohort with a cohort of patients without GCA of similar age, sex, and calendar year from the same population. Results. The study included 245 patients with GCA and 245 non-GCA subjects. The mean ± SD Framingham cardiovascular risk score was 30{\%} ± 19{\%} in GCA patients and 34{\%} ± 23{\%} in non-GCA subjects (P = 0.096) at the incidence/index date. Diabetes mellitus was significantly less common in GCA patients than non-GCA subjects at the index date. The mean high-density lipoprotein was higher and triglycerides were lower, with fewer patients taking lipid-lowering medications in the GCA cohort compared to the non-GCA cohort at the index date. During followup, no difference between the 2 cohorts was noted in the overall rate of ACS events (hazard ratio 0.74, 95{\%} confidence interval 0.44-1.26). Overall thrombosis in myocardial infarction scores were similar in both cohorts. Revascularization procedures were done less frequently in GCA than in non-GCA subjects (19{\%} versus 50{\%}; P = 0.015). Post-ACS hospital length of stays and complications were similar in both cohorts. Conclusion. Multiple cardiovascular risk factors are less atherogenic at incidence of GCA. There is no overall increased risk of ACS in patients with GCA.",
author = "Udayakumar, {Prabhu D.} and Chandran, {Arun K.} and Cynthia Crowson and Warrington, {Kenneth J} and Matteson, {Eric Lawrence}",
year = "2015",
month = "3",
day = "1",
doi = "10.1002/acr.22416",
language = "English (US)",
volume = "67",
pages = "396--402",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Cardiovascular risk and acute coronary syndrome in giant cell arteritis

T2 - A population-based retrospective cohort study

AU - Udayakumar, Prabhu D.

AU - Chandran, Arun K.

AU - Crowson, Cynthia

AU - Warrington, Kenneth J

AU - Matteson, Eric Lawrence

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Objective. To assess the occurrence of acute coronary syndrome (ACS) in patients with giant cell arteritis (GCA) compared to subjects without GCA. Methods. We retrospectively reviewed a population-based incidence cohort of Olmsted County, Minnesota residents with GCA diagnosed in 1950-2009. We compared this cohort with a cohort of patients without GCA of similar age, sex, and calendar year from the same population. Results. The study included 245 patients with GCA and 245 non-GCA subjects. The mean ± SD Framingham cardiovascular risk score was 30% ± 19% in GCA patients and 34% ± 23% in non-GCA subjects (P = 0.096) at the incidence/index date. Diabetes mellitus was significantly less common in GCA patients than non-GCA subjects at the index date. The mean high-density lipoprotein was higher and triglycerides were lower, with fewer patients taking lipid-lowering medications in the GCA cohort compared to the non-GCA cohort at the index date. During followup, no difference between the 2 cohorts was noted in the overall rate of ACS events (hazard ratio 0.74, 95% confidence interval 0.44-1.26). Overall thrombosis in myocardial infarction scores were similar in both cohorts. Revascularization procedures were done less frequently in GCA than in non-GCA subjects (19% versus 50%; P = 0.015). Post-ACS hospital length of stays and complications were similar in both cohorts. Conclusion. Multiple cardiovascular risk factors are less atherogenic at incidence of GCA. There is no overall increased risk of ACS in patients with GCA.

AB - Objective. To assess the occurrence of acute coronary syndrome (ACS) in patients with giant cell arteritis (GCA) compared to subjects without GCA. Methods. We retrospectively reviewed a population-based incidence cohort of Olmsted County, Minnesota residents with GCA diagnosed in 1950-2009. We compared this cohort with a cohort of patients without GCA of similar age, sex, and calendar year from the same population. Results. The study included 245 patients with GCA and 245 non-GCA subjects. The mean ± SD Framingham cardiovascular risk score was 30% ± 19% in GCA patients and 34% ± 23% in non-GCA subjects (P = 0.096) at the incidence/index date. Diabetes mellitus was significantly less common in GCA patients than non-GCA subjects at the index date. The mean high-density lipoprotein was higher and triglycerides were lower, with fewer patients taking lipid-lowering medications in the GCA cohort compared to the non-GCA cohort at the index date. During followup, no difference between the 2 cohorts was noted in the overall rate of ACS events (hazard ratio 0.74, 95% confidence interval 0.44-1.26). Overall thrombosis in myocardial infarction scores were similar in both cohorts. Revascularization procedures were done less frequently in GCA than in non-GCA subjects (19% versus 50%; P = 0.015). Post-ACS hospital length of stays and complications were similar in both cohorts. Conclusion. Multiple cardiovascular risk factors are less atherogenic at incidence of GCA. There is no overall increased risk of ACS in patients with GCA.

UR - http://www.scopus.com/inward/record.url?scp=84923282703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923282703&partnerID=8YFLogxK

U2 - 10.1002/acr.22416

DO - 10.1002/acr.22416

M3 - Article

C2 - 25074472

AN - SCOPUS:84923282703

VL - 67

SP - 396

EP - 402

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 3

ER -